IM Cannabis Corp (TSE:IMCC) has released an update.
IM Cannabis Corp., a leader in the medical cannabis sector, has enhanced its board of directors by appointing the former Deputy CEO of Leumi Group, Shmulik Arbel, known for his expertise in finance and corporate governance. Arbel’s extensive experience in banking is expected to bolster IM Cannabis’s strategic and profitable growth, particularly in its key markets of Israel and Germany. The company is committed to leveraging its data-driven approach and international operations to solidify its position as a top cannabis brand.
For further insights into TSE:IMCC stock, check out TipRanks’ Stock Analysis page.
